Wuppertal, Germany

Wolfgang Wuttke


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 43(Granted Patents)


Location History:

  • Wuppertal, DE (1977)
  • Wuppertal-Elberfeld, DE (1977)

Company Filing History:


Years Active: 1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wolfgang Wuttke

Introduction

Wolfgang Wuttke is a distinguished inventor based in Wuppertal, Germany. With a focus on developing novel compounds that exhibit significant therapeutic benefits, he has made notable contributions to the field of medicinal chemistry. His innovative work has yielded two patents that highlight his expertise in analgesic and anti-inflammatory agents.

Latest Patents

Wuttke's latest patents include groundbreaking formulations of 3-Carbo(lower alkoxy)hydrazinoindazoles and 3-Aminoindazole-1 and 2-carboxylic acid derivatives. The first patent involves compounds that are acylated with a carbo(lower alkoxy) group in the 3-position and are versatile in their potential applications as analgesic, anti-inflammatory, and antipyretic agents. A typical example from this patent is 3-carbomethoxyhydrazino-6-chloroindazole, which is produced by treating the relevant 3-hydrazinoindazole with a derivative of carbonic acid. The second patent focuses on 3-aminoindazoles featuring various functional groups that also exhibit similar therapeutic properties, with a highlighted compound being 3-amino-6-chloroindazole-1-carboxylic acid ethyl ester.

Career Highlights

Wolfgang Wuttke has built a notable career at Bayer Aktiengesellschaft, a leading global company in pharmaceuticals and life sciences. During his tenure, he has focused on the development of innovative compounds that contribute to effective pain management and inflammation reduction. His dedication to scientific research and innovation has forged a significant path in the industry.

Collaborations

Wuttke has collaborated with esteemed colleagues such as Karl Heinrich Mayer and Friedrich Hoffmeister. Together, they have successfully advanced research initiatives that enhance the understanding and application of therapeutic compounds. These collaborations have not only enriched Wuttke's work but also contributed to the broader scientific community.

Conclusion

With an emphasis on innovative medicinal chemistry, Wolfgang Wuttke continues to push the boundaries of pharmaceutical research. His patents represent a commitment to developing effective therapeutic agents that can improve the quality of life for many. As he continues his work at Bayer Aktiengesellschaft, the impact of his inventions will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…